PILERI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 6.976
NA - Nord America 6.357
EU - Europa 3.858
AF - Africa 428
Continente sconosciuto - Info sul continente non disponibili 394
SA - Sud America 332
OC - Oceania 20
Totale 18.365
Nazione #
US - Stati Uniti d'America 6.203
VN - Vietnam 2.217
SG - Singapore 1.727
CN - Cina 1.524
IT - Italia 865
GB - Regno Unito 746
HK - Hong Kong 544
DE - Germania 487
SE - Svezia 477
IN - India 286
FR - Francia 254
BR - Brasile 224
RU - Federazione Russa 204
ZA - Sudafrica 179
KR - Corea 155
IE - Irlanda 134
UA - Ucraina 129
BD - Bangladesh 128
NL - Olanda 124
CI - Costa d'Avorio 94
JP - Giappone 94
FI - Finlandia 77
CA - Canada 76
BG - Bulgaria 72
TG - Togo 54
CH - Svizzera 53
EE - Estonia 50
AR - Argentina 44
MX - Messico 42
ID - Indonesia 39
PH - Filippine 39
AT - Austria 34
TR - Turchia 32
PL - Polonia 31
SC - Seychelles 29
ES - Italia 27
JO - Giordania 27
TH - Thailandia 27
NG - Nigeria 26
AU - Australia 19
EC - Ecuador 18
IR - Iran 18
TW - Taiwan 18
IQ - Iraq 15
UZ - Uzbekistan 15
CO - Colombia 14
SA - Arabia Saudita 14
CL - Cile 13
BE - Belgio 12
EG - Egitto 12
HR - Croazia 12
LT - Lituania 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 9
LB - Libano 7
CZ - Repubblica Ceca 6
DK - Danimarca 6
JM - Giamaica 6
PT - Portogallo 6
RO - Romania 6
TN - Tunisia 6
UY - Uruguay 6
GR - Grecia 5
HU - Ungheria 5
MD - Moldavia 5
PY - Paraguay 5
RS - Serbia 5
VE - Venezuela 5
DZ - Algeria 4
IL - Israele 4
MY - Malesia 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
CR - Costa Rica 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
SV - El Salvador 3
AG - Antigua e Barbuda 2
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
GP - Guadalupe 2
KE - Kenya 2
MK - Macedonia 2
MM - Myanmar 2
MU - Mauritius 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
Totale 17.948
Città #
Singapore 1.171
Southend 619
Ashburn 613
Ho Chi Minh City 551
Fairfield 548
Hong Kong 512
Hanoi 458
San Jose 452
Chandler 450
Hefei 325
Santa Clara 297
Beijing 227
Houston 223
Woodbridge 220
Seattle 218
Wilmington 218
Princeton 185
Bologna 172
Cambridge 158
Boardman 148
Dong Ket 140
Dublin 134
Seoul 134
Johannesburg 115
Los Angeles 109
New York 103
Ann Arbor 102
Abidjan 94
Lauterbourg 94
Dallas 84
Tokyo 76
Da Nang 72
Council Bluffs 69
Haiphong 66
Nanjing 65
Sofia 65
Westminster 65
Jacksonville 62
Milan 56
Redmond 56
Helsinki 55
Berlin 54
Lomé 54
Redondo Beach 50
Buffalo 49
Padova 43
Rome 41
Saint Petersburg 41
Bremen 39
Frankfurt am Main 39
Jinan 39
San Diego 38
London 36
Chicago 34
Turin 34
São Paulo 33
Munich 32
Redwood City 30
Shenyang 30
Bengaluru 28
Thái Nguyên 28
Amman 27
Can Tho 27
Changsha 27
Quận Bình Thạnh 27
Vienna 27
Abeokuta 25
Bern 25
Tianjin 25
Hải Dương 24
Ha Long 23
Shanghai 23
Biên Hòa 22
Hangzhou 22
Hebei 22
Jakarta 22
Warsaw 22
Zhengzhou 22
Guangzhou 21
Nanchang 21
Phoenix 21
San Francisco 21
Vũng Tàu 21
Bangkok 19
Falls Church 19
Florence 19
Montreal 18
Delhi 17
Des Moines 17
Mexico City 17
Mülheim 17
Bắc Ninh 16
Norwalk 16
Nuremberg 16
Orem 16
Quận Sáu 16
Verona 16
Bắc Giang 15
Ninh Bình 15
Olalla 15
Totale 11.154
Nome #
Merkel cell carcinoma: a prompt diagnosis to increase survival 662
Napkin psoriasis and the risk of later psoriasis development: A single-centre retrospective study 370
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 273
Management of malignant cutaneous wounds in oncologic patients 262
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine 258
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 243
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 227
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 227
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 223
Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysis 211
Herpes zoster in COVID-19-positive patients 210
Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features. 203
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 200
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 196
Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). 187
Atopic Dermatitis and the Atopic March: What Is New? 186
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 185
Photodynamic therapy: An option in mycosis fungoides 185
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 182
Anaplastic Large Cell Lymphoma: a critical reappraisal 181
Chilblain lupus erythematosus in a patient affected by Hodgkin lymphoma 181
Annular lesions located on the right forearm. 177
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 175
Mycosis fungoides following pityriasis lichenoides: An exceptional event or a potential evolution? 174
Atypical piloleiomyoma of the face presenting with central ulceration 173
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 171
Cutaneous adverse-events in patients treated with Ibrutinib 170
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 167
Rosacea-like tinea incognito 167
Chilblain lesions after COVID-19 mRNA vaccine 166
Granulomatous tattoo reaction in a nivolumab-treated patient 165
Leukemia cutis in a Ph+ ALL patient treated with ponatinib 165
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 164
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 161
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 158
Large granular lymphocytic leukaemia mimicking ulcer of the lower limb 158
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 158
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 157
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 157
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region 155
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 155
Vemurafenib mucosal side-effect. 154
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 153
Bosentan and Extracorporeal Photochemotherapy in Eosinophilic Fasciitis: Synergistic Action or Fortuitous Coincidence? 151
An asymptomatic plaque on the chest: A quiz 148
Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopy 147
Persistent agmination of lymphomatoid papulosis: an ongoing debate. 147
Alopecia areata-like mycosis fungoides: Lions for lambs 145
Nb‐UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single‐center cross‐sectional study 144
Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine. 144
Papular mycosis fungoides: a new casa expanding the spectrum of phenotypic and clinical findings 143
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 142
Brownish asymptomatic lesions on the arms and legs 142
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 140
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 140
The karma of Kikuchi's disease. 139
Dermatofibrosarcoma protuberans secondary to a decorative tattoo: An Isotattootopic Response? 139
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 136
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 135
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 135
Erythematous induration of the chest 134
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 134
Epcoritamab injection site skin eruption: a frequent yet unharmful effect due to a local delayed reaction mechanism 132
A large mass and erythematous-violaceous plaques - Ein großer tumor und livid-erythematöse plaques 131
Multiple familial trichodiscomas. 130
TOX Expression in Mycosis Fungoides and Sezary Syndrome 129
Peripheral T-cell lymphoma. 129
Extramedullary metastatic plasmacytoma in a multiple myeloma patient 129
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis 129
Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients 128
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model 128
Multiple Eruptive Sebaceous Hyperplasia Secondary to Muir-Torre Syndrome Treated With Fractional Carbon Dioxide Laser Resurfacing Technique: A Case Report 127
Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace 127
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome? 127
Indolent lymphoma: the pathologist's viewpoint 127
New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia 125
Lymphoma classification: Past, present and future 124
Squamous cell carcinoma developed after ingenol mebutate therapy: A possible consequence of the treatment? 124
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report 122
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma 121
A rapidly growing ulcer: an atypical presentation of Merkel cell carcinoma 120
Lymphoma classification: the quiet after the storm. 119
Folliculotropic mycosis fungoides of the face successfully treated combining CO2 laser and conventional photodynamic therapy (c-PDT) 117
The role of myeloid derived suppressor cells in mycosis fungoides 116
Mycosis fungoides: disease evolution of the "lion queen" revisited. 115
Pityriasis lichenoides triggered by measles-mumps-rubella vaccine injection 115
Verrucous mycosis fungoides. 112
Erosive pustular dermatosis of the leg: An uncommon entity? 111
Is Dermoscopy Useful for the Diagnosis of Pseudolymphomas? 108
Sézary Syndrome without erythroderma featuring a CD30+ progression 105
The best teaching ulcer? The one we cannot label—addressing data scarcity through synthetic imaging 104
Unilesional folliculotropic mycosis fungoides: a true rarity in the clinico-pathologic spectrum? 103
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 102
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 102
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 100
Cutaneous involvement in multiple myeloma. A rare entity 100
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 99
Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides 98
Dimethyl fumarate: a case of improvement of alcoholic steatohepatitis in an elderly psoriatic patient 98
A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis 96
Totale 15.766
Categoria #
all - tutte 51.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.515 0 45 99 137 148 98 27 137 88 137 337 262
2022/20231.880 208 264 107 247 140 152 69 144 265 63 154 67
2023/2024593 39 109 33 48 35 109 80 44 10 36 18 32
2024/20252.752 108 363 220 213 438 103 240 100 56 176 168 567
2025/20267.664 851 1.107 583 492 728 391 629 329 1.353 573 342 286
2026/2027305 301 4 0 0 0 0 0 0 0 0 0 0
Totale 18.365